MRNA - Spark Newswire

1 minute read

Uncategorized

India To Skip Local Trials for ‘Well Established’ COVID-19 Vaccines; Pfizer Shots May Arrive By July: Reuters

Today, 11:12 AM

As a step to accelerate vaccination rollout, India has reportedly scrapped local trials for “well-established” foreign COVID-19 vaccines, with a…

AZN

2 minute read

Uncategorized

Here’s What Is Going On With Ocugen (OCGN) Stock

By Madhukumar Warrier

Today, 11:12 AM

Shares of Ocugen Inc. (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, fell 3.7% in Wednesday’s regular trading session.

BNTX

1 minute read

Uncategorized

Nipro To Provide Fill, Finish Services For AstraZeneca COVID-19 Shots In Japan: Reuters

By Vandana Singh

Today, 11:12 AM

Japan’s Nipro Corporation has signed an agreement to supply AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine in Japan, reports Reuters. Nipro said that the…

AZN

1 minute read

Uncategorized

Moderna Sees Single-Dose COVID-19 Vaccine Launch In India In 2022

By Vandana Singh

Today, 11:12 AM

Moderna Inc (NASDAQ: MRNA) expects to launch a single-dose COVID-19 vaccine in India in 2022 and is in talks…

BNTX

1 minute read

Uncategorized

Fauci Says High School Students May Be Vaccinated By School Year; May Be Vaccinated With Pfizer, Moderna

By Benzinga Newsdesk

Today, 11:12 AM

-Reuters

BNTX

1 minute read

Uncategorized

Moderna Expected To Launch Single-Dose COVID-19 Shot In India

By Benzinga Newsdesk

Today, 11:12 AM

-Reuters

MRNA

2 minute read

Uncategorized

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation

By Shanthi Rexaline

Today, 11:12 AM

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.

ASND

2 minute read

Uncategorized

Pfizer Hits Deadlock With India Over Vaccine Indemnity Issue: Reuters

By Vandana Singh

Today, 11:12 AM

Pfizer Inc (NYSE: PFE) and the Indian government are at loggerheads over a demand by the company for legal protection from any claims linked to the use of its COVID-19 vaccine, said

AZN

4 minute read

Uncategorized

Ministry Of Food And Drug Safety of South Korea Authorizes Moderna’s COVID-19 Vaccine; Co Secures 40M Doses Of Vaccine

By Benzinga Newsdesk

Today, 11:12 AM

Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna's COVID-19 Vaccine South Korea has secured 40 million doses of COVID-19 Vaccine Moderna Moderna, Inc. (NASDAQ:MRNA), a biotechnology

MRNA

1 minute read

Uncategorized

Japan Approves AstraZeneca’s COVID Vaccine, But Puts Use on Hold Amid Blood Clot Concern

By Vandana Singh

Today, 11:12 AM

Along with the approval of Moderna’s COVID-19 vaccine, Japan’s regulatory authority has also approved AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine, Vaxzevria for…

AZN

Feed Symbols: MRNA